These mechanisms were observed in human endothelial cells and monocytes, where it has been found that 2 μg/mL of CRC reduces IL-1β in HUVECs and reduces IL-6 and TNF-α in THP-1 cells [93]. This evidence concerns the gene IL1B and colorectal carcinoma.